For each of the mTOR kinase inhibitors used, the use of the combination with the MEK1/2 kinase AS-703026 inhibitor gave a clear synergistic effect both in caspase 3 activity, activation of the apoptosis process and inhibition of melanoma cell proliferation. This evidence concerns the gene CASP3 and melanoma.